AMPATH and Lilly Partnership

Partnership objective

Support AMPATH in providing screening and care for cancer and other chronic illnesses, which would otherwise be out of reach for most patients in Kenya.

The AMPATH Oncology Institute provides access to quality cancer care to the 18 million people residing in western Kenya. The AMPATH Oncology Institute provides access to quality cancer care to the 18 million people residing in western Kenya. Copyright AMPATH

What are the health needs and challenges?

Many people in Kenya live in poverty and lack access to quality healthcare. Screening, diagnosis, treatment and palliative care for cancer are in very scarce supply in Kenya, with only two cancer centers for the country’s 42 million people. Much of the screening and care provided could only be done in substandard facilities. 

Description of partnership activities and how they address needs and challenges

The Academic Model Providing Access to Healthcar (AMPATH) was created in response to the HIV crisis in Western Kenya in 2001. It is built on a partnership with Moi Teaching and Referral Hospital and the Moi University School of Medicine in Eldoret, Kenya, and a consortium of North American academic health centers, led by Indiana University. AMPATH has continually expanded its successful HIV approach to include more diseases, including diabetes, hypertension and cancer.

As an extension of this work, the AMPATH Oncology Institute was launched in 2009—with a single physician and nurse. Public-private partnerships have allowed the institute to expand its staff and services to a current team that includes 10 clinicians, six core nurses and an oncology pharmacist. The institute received nearly 10,000 patient visits last year and screened more than 10,000 women for breast cancer and 20,000 women for cervical cancer. But demand far outstrips supply.

Since 2002, Lilly has donated nearly $60 million in medicines to AMPATH to improve health for people with diabetes, mental illness and cancer. In February 2015 Lilly Foundation announced an additional commitment of $1 million to AMPATH. The funding helped equipping a new oncology center, hire additional staff and train local healthcare professionals—ultimately allowing AMPATH to screen, treat and provide palliative care to more people, many of whom lack access to quality health services.

The Lilly Foundation's funding helped equip the center's new oncology outpatient center and allowed for the hiring of additional doctors, physicians' assistants and other staff to screen and treat more people. Additionally, the funding supports the creation of a research and training institute focused on cancer prevention, screening, treatment and supportive care. The institute also helps building much-needed capacity among local healthcare providers.The AMPATH Oncology Institute provides access to quality cancer care to the 18 million people residing in western Kenya.

AMPATH’s new four-story Chandaria Cancer and Chronic Diseases Center opened in 2015.


AMPATH and Lilly Partnership

Partnership information

Company(ies) Eli Lilly and Company

Partner(s) Academic Model Providing Access to Healthcare (AMPATH), Indiana University, Moi University School of Medicine

Type of Partner(s) Academia / Hospitals

Therapeutic Focus Other, Non-Communicable Diseases

Disease(s) Cancer, Palliative Care

Program Type(s) Availability of Treatment - Financial Support, Availability of Treatment - Product Donations, Health System Infrastructure - Development of Physical Infrastructure, Health System Infrastructure - Outreach & Medical Services, Health System Infrastructure - Training

Targeted Population(s) General population, Patients in needs of treatment, People with low income

Region(s) Sub-Saharan Africa

Number of Countries 1

Country(ies) Kenya

Start Date 2002

More information Lilly Press Release

Anticipated completion date Ongoing

« All successes in AMPATH and AMPATH Oncology stem from belief in an authentic international partnership, based on committed friendship and trust, that serves cancer patients wherever they live. »

Pat Loehrer, M.D., director of the Indiana University Melvin and Bren Simon Cancer Center and co-founder of AMPATH Oncology Institute